Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (MCK)
NYSE:MCK
MCK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$464.42 - $737.89
Previous CloseN/A
Volume137.88K
Average Volume (3M)739.49K
Market Cap
$83.16B
Enterprise Value$100.32B
Total Cash (Recent Filing)$5.69B
Total Debt (Recent Filing)$7.39B
Price to Earnings (P/E)26.7
Beta0.27
Next Earnings
Nov 04, 2025EPS Estimate
8.85Next Dividend Ex-Date
Sep 02, 2025Dividend Yield0.42%
Share Statistics
EPS (TTM)8.26
Shares Outstanding124,384,390
10 Day Avg. Volume1,045,434
30 Day Avg. Volume739,493
Financial Highlights & Ratios
PEG Ratio1.77
Price to Book (P/B)-41.34
Price to Sales (P/S)0.24
P/FCF Ratio16.41
Enterprise Value/Market Cap1.21
Enterprise Value/Revenue0.28
Enterprise Value/Gross Profit7.53
Enterprise Value/Ebitda19.07
Forecast
1Y Price Target
$791.38Price Target Upside18.37% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Acquisition StrategyThe completion of the acquisition of a 70% stake in Core Ventures shifts focus away from deal timing and back to core results, highlighting positive developments for McKesson.
Financial GuidanceManagement expressed confidence in the future performance of the US Pharma segment, raising its guidance to the upper half of the 12-16% range.
Operational PerformanceThe increase in McKesson's EPS guidance is attributed to operational strength across various segments, which is a modest positive for the company.
Bears Say
Business DivestitureThere are lingering investor questions regarding the timing of McKesson's plan to divest its Medical Surgical business.
Investor ConcernsThe Most-Favored-Nation Drug Pricing Executive Order has generated some investor concern, with potential neutral to negative impact on distributors.
Market PerformancePeer COR's US Healthcare performance had more upside than MCK's US Pharma segment.
McKesson News
MCK FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest stock price was $464.42 and its highest was $737.89 in the past 12 months.
What is Mckesson Corp.’s market cap?
Mckesson Corp.’s market cap is $83.16B.
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is Nov 04, 2025 which is in 85 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Aug 06, 2025. The company reported $8.26 earnings per share for the quarter, beating the consensus estimate of $8.14 by $0.12.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $0.82 which represents an annual dividend yield of 0.42%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is 8.85.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 124,384,390 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $8.26 in its last earnings report, beating expectations of $8.14. Following the earnings report the stock price went down -5.756%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Currently, no hedge funds are holding shares in MCK
McKesson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$791.38 (18.37% Upside)
$791.38 (18.37% Upside)
Blogger Sentiment
Bullish
MCK Sentiment 87%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 300.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.1%
Last 30 Days ▼ 2.3%
Last 30 Days ▼ 2.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.66%
12-Months-Change
Fundamentals
Return on Equity
51.23%
Trailing 12-Months
Asset Growth
13.45%
Trailing 12-Months
Company Description
Mckesson Corp.
McKesson Corporation is a leading global healthcare services and information technology company headquartered in Irving, Texas. It operates primarily in the pharmaceutical distribution and healthcare services sectors, providing a comprehensive range of products and services to healthcare providers, including hospitals, pharmacies, and pharmaceutical manufacturers. McKesson's core offerings involve the distribution of pharmaceuticals and medical supplies, healthcare management software, and various technology solutions aimed at improving patient care and operational efficiency across the healthcare continuum.
MCK Company Deck
MCK Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
McKesson's earnings call conveyed a strong performance this quarter with substantial revenue growth and successful strategic acquisitions. Despite some challenges, such as the impact from Rite Aid's bankruptcy and the exit from European operations, the company showed robust operational execution and raised its full-year guidance, indicating a positive outlook.View all MCK earnings summariesMCK Revenue Breakdown
91.27% U.S. Pharmaceutical
4.10% International
3.17% Medical-Surgical Solutions
1.45% Prescription Technology Solutions
MCK Stock 12 Month Forecast
Average Price Target
$791.38
▲(18.37% Upside)
Technical Analysis
Cencora
―
Cardinal Health
―
Henry Schein
―
Owens & Minor
―
Prestige Consumer Healthcare
―
Ownership Overview
0.04% Insiders
25.45% Mutual Funds
1.56% Other Institutional Investors
50.95% Public Companies and Individual Investors